Treatment of Irinotecan Hydrochloride Liposome Injection II in China: a Real World Study of Pancreatic Cancer Patients
Conditions: Pancreatic Cancer Interventions: Drug: Irinotecan liposome II combination therapy regimen Sponsors: Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2024 Category: Research Source Type: clinical trials
Ivonescimab Combined With HAIC for the Treatment of Unresectable Hepatocellular Carcinoma （uHCC）.
Conditions: Hepatocellular Carcinoma Non-resectable; Hepatocellular Carcinoma Interventions: Drug: Ivonescimab （AK112，a PD-1/VEGF bispecific antibody） Sponsors: Tianjin Medical University Cancer Institute and Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2024 Category: Research Source Type: clinical trials
Natural History Study of Kaposi Sarcoma
Conditions: Kaposi Sarcoma; HIV Sponsors: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2024 Category: Research Source Type: clinical trials
The Effect of Foot Massage With Roles on Cancer Patients
Conditions: Breast Neoplasms; Over Cancer; Foot Massage Interventions: Other: Foot Massage with roller Sponsors: Selcuk University Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2024 Category: Research Source Type: clinical trials
Neoadjuvant Treatment Based on Gastric Cancer Molecular Subtyping.
Conditions: Advanced Gastric Cancer; Neoadjuvant Therapy; Multi-omics Analysis Interventions: Procedure: combination chemotherapy with Apatinib or Camrelizumab Sponsors: Fujian Medical University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2024 Category: Research Source Type: clinical trials
Fasting Mimicking Diet in Chemotherapy of Gynecologic Malignancies
Conditions: Cancer, Ovarian; Chemotherapy Effect; Calorie Deficiency; Fasting, Intermittent Interventions: Other: Fasting Mimicking Diet; Drug: Chemotherapy Sponsors: L-Nutra Inc; University of Tennessee Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2024 Category: Research Source Type: clinical trials
Tislelizumab Combined With Neoadjuvant Chemotherapy Used in the Perioperative Treatment.
Conditions: Gastric Cancer Interventions: Drug: Tislelizumab; Drug: SOX/XELOX Sponsors: Xiangdong Cheng; Liaoning Tumor Hospital& Institute; Shanxi Province Cancer Hospital; Sichuan Cancer Hospital and Research Institute; The Second Affiliated Hospital of Harbin Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2024 Category: Research Source Type: clinical trials
Sequential Intravesical Gemcitabine and Docetaxel for Rescue Therapy in BCG Unresponsive Non-muscle Invasive Bladder Cancer Patients
Conditions: Bladder Cancer; BCG; Gemcitabine; Docetaxel; Intravesical Instillation Interventions: Drug: Intravesical Solution Sponsors: Dokuz Eylul University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2024 Category: Research Source Type: clinical trials
The Effect of Tennis Ball on Balance and Quality of Life in Cancer Patients With Neuropathy.
Conditions: Cancer; Neuropathy; Therapy-Associated Cancer Interventions: Other: myofascial release with tennis ball Sponsors: Selcuk University Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2024 Category: Research Source Type: clinical trials
Improving Colonoscopy Surveillance for Patients With High Risk Colon Polyps
Conditions: Colorectal Carcinoma Interventions: Other: Best Practice; Other: Communication Intervention; Other: Communication Intervention; Other: Communication Intervention; Other: Interview; Other: Interview Sponsors: Jonsson Comprehensive Cancer Center; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2024 Category: Research Source Type: clinical trials
Osimertinib With Chemotherapy as First-line Therapy for EGFR Mutation-positive NSCLC
Conditions: Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Respiratory Tract Neoplasms; Thoracic Neoplasms; Neoplasms by Site; Neoplasms; Lung Diseases; Respiratory Tract Diseases; Carcinoma, Bronchogenic; Bronchial Neoplasms Sponsors: AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2024 Category: Research Source Type: clinical trials
EUS-Gallbladder vs CDS as First Line in MBDO- Palliative (CARPEGIEM Trial)
Conditions: Malignant Biliary Obstruction; Biliary Tract Neoplasms; Pancreatic Cancer Non-resectable Interventions: Procedure: Endoscopic biliary drainage; Device: Lumen-apposing metal stent (LAMS) and double-pigtail plastic stent (DPPS); Device: Lumen-apposing metal stent (LAMS) and double-pigtail plastic stent (DPPS) Sponsors: Hospital Universitari de Bellvitge; Hospital Cl ínico Universitario de Valencia; Hospital General Universitario de Alicante; Hospital Mutua de Terrassa; Hospital Universitario Ramon y Cajal; Hospital General Universitario de Castellón; Complejo Hospitalario de Navarra; University Hospital Virgen ...
Source: ClinicalTrials.gov - April 19, 2024 Category: Research Source Type: clinical trials
Robotic-Assisted or Laparoscopic Radical Resection for Rectal Cancer With or Without Left Colic Artery Preservation
Conditions: Rectal Cancer; Left Colic Artery Stenosis (Diagnosis); Robotic Assisted Laparoscopic Surgery Interventions: Procedure: with or without Left Colic Artery Preservation Sponsors: Daorong Wang Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2024 Category: Research Source Type: clinical trials
A Single Arm, Single Centered Phase II Trial on the Combination of Adebrelimab, Surufatinib and Irinotecan Liposome-based HAIC in Advanced iCC
Conditions: Intrahepatic Cholangiocarcinoma Interventions: Drug: Adebrelimab Sponsors: Tianjin Medical University Cancer Institute and Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2024 Category: Research Source Type: clinical trials
Stereotactic Body Proton Therapy for Treatment of Primary Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma Interventions: Radiation: Proton Stereotactic Body Radiation therapy (SBRT) Sponsors: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2024 Category: Research Source Type: clinical trials
